Myloablative Cord Blood Transplant in Haematological Malignancies (MAC UCBT)
Status:
Terminated
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
This trial is looking at using umbilical cord blood from unrelated donors after high dose
chemotherapy. It is for people who have cancer of the bone marrow or lymphatic system
including leukaemia and lymphoma, or a blood disorder called myelodysplastic syndrome (MDS).
The trial is for babies over 4 weeks old, children, and adults up to the age of 45.